← Patenter
Venture investors

Everyone has patents. Are they worth anything?

An issued patent is not the same as a strong one. Outside opinions on every asset in a deal are slow and expensive, so most diligence checks a few patents, or takes the portfolio on trust. Patenter identifies the risks in every patent and application in the deal, on your timeline, at a fixed price per asset.

Evaluate a single patent or application now, at a fixed price, or contact us to evaluate the whole portfolio.

Issued is not the same as strong

A patent in the data room is a question, not an answer.

Issued means an examiner allowed the claims. It does not mean they would survive a challenge from a well-funded competitor, cover the product the company actually sells, or leave room to sell it without licensing a blocking patent. And a pending application is worth little until you know whether its claims are likely to issue. An outside opinion answers those questions for one asset at a time, at a price that rules out doing it for the whole portfolio. Patenter identifies those risks in every asset in the deal. At scale.

  • →Validity exposure: the claims checked against 5M+ patents and publications
  • →Pending applications: how likely the claims as filed are to survive examination against the prior art
  • →Freedom to operate: claim charts for the blocking patents that could stop the company from practicing its own product
  • →A recommended path and a risk posture for each asset
  • →One view of the portfolio, so the strong assets stand out from the filler
How patent assessments work →
FTO claim chart · US10,890,721 claim 1
Clearance
Clear
Elements met
2 of 4
1[a] housing with inlet and outletPresent
1[b] electrode array, spacing < 3 mmPresent
1[c] continuous DC fieldAbsent
1[d] replaceable collection mediaAbsent
Patent assessments

Diligence on a deal timeline.

Run an assessment on every patent and application in a target's portfolio, at a fixed price per asset, and see where the IP is strong, where it's exposed and what to ask the founders.

  • →One assessment per patent or application, for the whole portfolio
  • →Freedom-to-operate claim charts that flag commercialization risks
  • →Conservative and aggressive risk posture, per asset
  • →Reports you can attach to an investment memo
How patent assessments work →
Deal assessments · Investor viewpreview
Overview
12
Assets
7
Clear
3
Caution
2
Blocked
Recommendations
RiskCore asset blocked by US9,832,114
Ask founders
NoteClaim 7 possibly anticipated
Narrow?
Strong3 broad claims likely novel
Value↑

Portfolio evaluation

We evaluate the target's full portfolio, every issued patent and pending application, and give you one view of what it is worth and where it is exposed.

Evaluate a patent now